Seeing Is Believing
INFI is currently covered by 1 analysts with an average price target of $2.89. This is a potential upside of $2.89 (0%) from yesterday's end of day stock price of $0.
Infinity Pharmaceuticals's activity chart (see below) currently has 26 price targets and 20 ratings on display. The stock rating distribution of INFI is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 29.17% with an average time for these price targets to be met of 61.5 days.
Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 24-Feb-2023. First documented stock forecast 15-Jun-2016.
Currently out of the existing stock ratings of INFI, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$3
1 years 8 months 30 days ago
(24-Feb-2023)
0/4 (0%)
$2.38 (383.87%)
Hold
$1.5
$1.5 (0.00%)
$3
2 years 7 days ago
(16-Nov-2022)
0/6 (0%)
$0.85 (130.77%)
Buy
$12
2 years 3 months 11 days ago
(12-Aug-2022)
0/1 (0%)
$8.8 (275.00%)
Buy
$4
$4 (0.00%)
$12
2 years 7 months 23 days ago
(31-Mar-2022)
0/3 (0%)
$2.86 (250.88%)
Hold
$6
$5.98 (29900.00%)
3 years 3 months 22 days ago
(02-Aug-2021)
0/1 (0%)
$3.07 (104.78%)
What is INFI (Infinity Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on INFI (Infinity Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on INFI (Infinity Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on INFI (Infinity Pharmaceuticals)?
Which analyst is the currently most bullish on INFI (Infinity Pharmaceuticals)?
Which analyst is the currently most reserved on INFI (Infinity Pharmaceuticals)?